Avita Medical

Avita Medical

Yahoo Finance • 2 days ago

Biotech Breakout: What's in focus after Moderna's cancer win?

[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [htt... Full story

Yahoo Finance • 8 days ago

AVITA rises as wound care product succeeds in U.S. burn center trial

AVITA Medical (RCEL [https://seekingalpha.com/symbol/RCEL]) traded higher on Tuesday after the wound care company said a randomized controlled clinical trial testing its biosynthetic wound matrix PermeaDerm across 11 U.S. burn centers succ... Full story

Yahoo Finance • 17 days ago

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to atten... Full story

Yahoo Finance • 20 days ago

Avita outlines $86M-$89M 2026 revenue and targets Q4 2026 cash flow break-even

Earnings Call Insights: AVITA Medical (RCEL) Q2 2026 MANAGEMENT VIEW * "We delivered strong revenue growth in the second quarter of $21.7 million, up 18% year-over-year and 13% sequentially," said "President, CEO & Executive Director C... Full story

Yahoo Finance • last month

Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data

(RTTNews) - Today's biotech movers include Apollomics following its return to Nasdaq compliance, Iovance and AVITA ahead of Q2 earnings updates, Annexon, awaiting topline data in dry age-related macular degeneration with geographic atrophy... Full story

Yahoo Finance • 4 months ago

AVITA Medical to Announce First Quarter 2026 Financial Results

VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial results after the cl... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical Inc. (“AVITA Medical” or the “Company”) (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 4 months ago

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

Recognition highlights pioneering contributions to modern burn care including development of RECELL® Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeuti... Full story

Yahoo Finance • 6 months ago

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, Interim CEO, and David O’T... Full story

Yahoo Finance • 9 months ago

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE:AGL), Soleno Therapeutics, Inc. (NASDAQ:SLN... Full story

Yahoo Finance • 9 months ago

AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference

VALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that the Company will present at the Pi... Full story

Yahoo Finance • 10 months ago

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE:AGL), Soleno Therapeutics, Inc. (NASDAQ:SLN... Full story

Yahoo Finance • 10 months ago

Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity

Earnings Call Insights: AVITA Medical, Inc. (RCEL) Q3 2025 MANAGEMENT VIEW * Cary Vance, Interim CEO, opened by acknowledging the challenging quarter and outlined, "We reported approximately $17 million in revenue, below expectations a... Full story

Yahoo Finance • 10 months ago

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today announced two podium presentations at the 2025 So... Full story

Yahoo Finance • 10 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results

VALENCIA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced tha... Full story

Yahoo Finance • 10 months ago

AVITA Medical Welcomes Support for RECELL® in Burns in Australia

Australia’s Medical Services Advisory Committee (MSAC) recognizes RECELL® as safe and effective, with benefits in healing, donor site sparing, and reduced hospital stays VALENCIA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical,... Full story

Yahoo Finance • 10 months ago

AVITA Medical Announces CEO Transition

Board Chairman Cary Vance appointed Interim CEO Board member Jan Stern Reed appointed Lead Independent Director Third quarter 2025 preliminary revenue expected to be approximately $17 million VALENCIA, Calif., Oct. 16, 2025 (GLOBE NEWSW... Full story

Yahoo Finance • 10 months ago

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Avita and would like to discuss... Full story

Yahoo Finance • 11 months ago

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Avita and would like to discuss... Full story

Yahoo Finance • 11 months ago

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Hospitals may receive up to $4,875 in added reimbursement when using RECELL to treat non-burn full-thickness acute wounds resulting from trauma or surgery Effective October 1, the add-on payment eases financial barriers, supporting broade... Full story